Business ❯Pharmaceutical Industry

Company Performance

Stock Market Novo Nordisk Johnson & Johnson

Novo Nordisk's Obesity Pill Shows Modest Results, Stocks Drop

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study

Ro Launches GLP-1 Supply Tracker Amid Rising Drug Costs

Johnson & Johnson Reports Mixed Q1 Results, Adjusts Full-Year Guidance